رجوع
41
نطاق اليوم
KWD 66.34
KWD 68.27
نطاق 52 أسبوعًا
KWD 66.34
KWD 107.27
حجم التداول
592,223
متوسط 50 يوم / 200 يوم
KWD 78.50
/
KWD 84.96
الإغلاق السابق
KWD 68.13
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 31.2 | 0.3 |
| P/B | 2.5 | 2.9 |
| ROE % | 8.7 | 3.7 |
| Net Margin % | 8.5 | 3.8 |
| Rev Growth 5Y % | 9.0 | 10.0 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 100.670
+49.0%
Low: KWD 78.000
High: KWD 108.000
مكرر الربحية المستقبلي
16.8
ربحية السهم المستقبلية
KWD 4.062
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.6 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 5.230
KWD 5.157 – KWD 5.310
|
2.1 B | 1 |
| FY2029 |
KWD 4.970
KWD 4.901 – KWD 5.046
|
1.9 B | 1 |
| FY2028 |
KWD 4.648
KWD 4.442 – KWD 4.853
|
1.8 B | 2 |
النقاط الرئيسية
Revenue grew 8.98% annually over 5 years — modest growth
Generating 215.65M in free cash flow
P/E of 31.24 — premium valuation
Cash machine — converts 167.84% of earnings into free cash flow
Capital efficient — spends only 5.39% of revenue on capex
النمو
Revenue Growth (5Y)
8.98%
Revenue (1Y)11.75%
Earnings (1Y)6.76%
FCF Growth (3Y)41.01%
الجودة
Return on Equity
8.67%
ROIC5.58%
Net Margin8.48%
Op. Margin12.19%
الأمان
Debt / Equity
0.57
Current Ratio4.34
Interest Coverage6.98
التقييم
P/E Ratio
31.24
P/B Ratio2.53
EV/EBITDA24.17
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.75% | Revenue Growth (3Y) | 9.80% |
| Earnings Growth (1Y) | 6.76% | Earnings Growth (3Y) | 16.66% |
| Revenue Growth (5Y) | 8.98% | Earnings Growth (5Y) | 27.61% |
| Profitability | |||
| Revenue (TTM) | 1.52B | Net Income (TTM) | 128.49M |
| ROE | 8.67% | ROA | 4.78% |
| Gross Margin | 48.70% | Operating Margin | 12.19% |
| Net Margin | 8.48% | Free Cash Flow (TTM) | 215.65M |
| ROIC | 5.58% | FCF Growth (3Y) | 41.01% |
| Safety | |||
| Debt / Equity | 0.57 | Current Ratio | 4.34 |
| Interest Coverage | 6.98 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 31.24 | P/B Ratio | 2.53 |
| P/S Ratio | 2.65 | PEG Ratio | 8.40 |
| EV/EBITDA | 24.17 | Dividend Yield | 0.00% |
| Market Cap | 4.01B | Enterprise Value | 4.46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.52B | 1.36B | 1.26B | 1.15B | 1.07B |
| Net Income | 128.49M | 120.36M | 94.41M | 74.52M | 48.45M |
| EPS (Diluted) | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 |
| Gross Profit | 738.27M | 643.33M | 583.87M | 519.10M | 485.33M |
| Operating Income | 184.72M | 155.69M | 123.94M | 87.56M | 60.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.69B | 2.42B | 2.33B | 1.66B | 1.65B |
| Total Liabilities | 1.10B | 1.04B | 1.12B | 519.57M | 608.50M |
| Shareholders' Equity | 1.58B | 1.38B | 1.20B | 1.14B | 1.04B |
| Total Debt | 898.23M | 794.67M | 891.36M | 279.76M | 325.70M |
| Cash & Equivalents | 448.50M | 376.72M | 587.04M | 58.41M | 67.75M |
| Current Assets | 1.04B | 923.77M | 1.11B | 529.08M | 482.21M |
| Current Liabilities | 239.76M | 216.40M | 203.56M | 220.65M | 236.28M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#604 of 1052
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026